Phase I/II clinical trial - Pédiatrie Tumeurs cérébrales
Pédiatrie Tumeurs cérébrales
Essai clinique fermé
Phase Ib /II Clinical Trial of Nivolumab Monotherapy and Nivolumab in Combination with Ipilimumab in Pediatric Subjects with High Grade Primary CNS Malignancies.
Description de l'essai
The purpose of this study is to determine the safety and effectiveness of nivolumab alone and in combination with ipilimumab in pediatric patients with high grade primary central nervous system (CNS) malignancies.